Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
ALXN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.27%93.671.3%$1008.13m
BIIBBiogen Inc.
0.78%232.001.3%$692.44m
AMGNAmgen Inc.
1.93%179.761.3%$470.05m
GILDGilead Sciences, Inc.
0.33%63.250.9%$443.00m
ILMNIllumina, Inc.
0.93%322.063.5%$285.16m
REGNRegeneron Pharmaceuticals, Inc.
0.83%347.002.6%$277.64m
VRTXVertex Pharmaceuticals Incorporated
4.07%175.371.9%$247.10m
ALXNAlexion Pharmaceuticals, Inc.
2.64%132.372.0%$175.19m
EXASExact Sciences Corporation
3.61%93.9425.3%$160.74m
SRPTSarepta Therapeutics, Inc.
3.78%118.0914.7%$144.55m
AAgilent Technologies, Inc.
-0.04%75.541.6%$142.04m
ONCESpark Therapeutics, Inc.
0.00%110.6011.2%$133.55m
INCYIncyte Corporation
2.38%75.412.5%$98.69m
IONSIonis Pharmaceuticals, Inc.
3.25%75.008.3%$95.31m
BMRNBioMarin Pharmaceutical Inc.
2.74%86.004.3%$93.68m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.